Role of TPMT and COMT genetic variation in cisplatin-induced ototoxicity

被引：17
作者：
Carleton, B. C. [1 ,2 ,3 ]
Ross, C. J. [1 ,2 ,3 ,4 ]
Bhavsar, A. P. [1 ]
Amstutz, U. [1 ,2 ,3 ]
Pussegoda, K. [1 ]
Visscher, H. [1 ]
Lee, J. W. [1 ,4 ]
Brooks, B. [5 ]
Rassekh, S. R. [1 ,6 ]
Dube, M-P [7 ,8 ]
Hayden, M. R. [1 ,4 ]
机构：
[1] Univ British Columbia, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada
[2] Univ British Columbia, Dept Pediat, Div Translat Therapeut, Vancouver, BC V6T 1W5, Canada
[3] BC Childrens Hosp, Pharmaceut Outcomes Programme, Vancouver, BC, Canada
[4] Univ British Columbia, Dept Med Genet, Ctr Mol Med & Therapeut, Vancouver, BC, Canada
[5] British Columbia Childrens Hosp, Audiol & Speech Pathol Dept, Vancouver, BC V6H 3V4, Canada
[6] British Columbia Childrens Hosp, Dept Pediat, Div Pediat Hematol Oncol Bone Marrow Transplant, Vancouver, BC V6H 3V4, Canada
[7] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada
[8] Univ Montreal, Montreal, PQ, Canada
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2014年 / 95卷 / 03期
基金：
加拿大健康研究院;
关键词：
HEARING-LOSS; CHILDREN; VARIANTS;
D O I：
10.1038/clpt.2013.219
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：253 / 253
页数：1
相关论文
共 5 条
  • [1] Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma
    Fouladi, Maryam
    Chintagumpala, Murali
    Ashley, David
    Kellie, Stewart
    Gururangan, Sridharan
    Hassall, Tim
    Gronewold, Lindsey
    Stewart, Clinton F.
    Wallace, Dana
    Broniscer, Alberto
    Hale, Gregory A.
    Kasow, Kimberly A.
    Merchant, Thomas E.
    Morris, Brannon
    Krasin, Matthew
    Kun, Larry E.
    Boyett, James M.
    Gajjar, Amar
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (22) : 3749 - 3755
  • [2] Replication of TPMT and ABCC3 Genetic Variants Highly Associated With Cisplatin-Induced Hearing Loss in Children
    Pussegoda, K.
    Ross, C. J.
    Visscher, H.
    Yazdanpanah, M.
    Brooks, B.
    Rassekh, S. R.
    Zada, Y. F.
    Dube, M-P
    Carleton, B. C.
    Hayden, M. R.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (02) : 243 - 251
  • [3] Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy
    Ross, Colin J. D.
    Katzov-Eckert, Hagit
    Dube, Marie-Pierre
    Brooks, Beth
    Rassekh, S. Rod
    Barhdadi, Amina
    Feroz-Zada, Yassamin
    Visscher, Henk
    Brown, Andrew M. K.
    Rieder, Michael J.
    Rogers, Paul C.
    Phillips, Michael S.
    Carleton, Bruce C.
    Hayden, Michael R.
    [J]. NATURE GENETICS, 2009, 41 (12) : 1345 - U118
  • [4] ENHANCED CIS-PLATINUM OTOTOXICITY IN CHILDREN WITH BRAIN-TUMORS WHO HAVE RECEIVED SIMULTANEOUS OR PRIOR CRANIAL IRRADIATION
    WALKER, DA
    PILLOW, J
    WATERS, KD
    KEIR, E
    [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 1989, 17 (01): : 48 - 52
  • [5] The Role of Inherited TPMT and COMT Genetic Variation in Cisplatin-Induced Ototoxicity in Children With Cancer
    Yang, J. J.
    Lim, J. Y. S.
    Huang, J.
    Bass, J.
    Wu, J.
    Wang, C.
    Fang, J.
    Stewart, E.
    Harstead, E. H.
    Robinson, G. W.
    Evans, W. E.
    Pappo, A.
    Zuo, J.
    Relling, M. V.
    Onar-Thomas, A.
    Gajjar, A.
    Stewart, C. F.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (02) : 252 - 259
1